Literature DB >> 8253154

Trypanosoma cruzi: antibody production and T cell response induced by stage-specific surface glycoproteins purified from metacyclic trypomastigotes.

N Yoshida1, J E Araya, J F da Silveira, S Giorgio.   

Abstract

The main surface glycoproteins of metacyclic trypomastigotes of Trypanosoma cruzi, gp90, gp82, and gp35/50, were purified and the immune response elicited by these antigens was analyzed. Balb/c mice immunized with antibody-affinity-purified gp82, plus alum as adjuvant, produced antibodies that recognized both the gp82 and the heterologous gp90 and gp35/50. On the other hand, antisera to gp90 reacted only with the homologous antigen, either by immunoprecipitation or by immunoblotting. Neither sera reacted with unrelated proteins in ELISA. Both antisera lysed 90-100% metacyclic forms in a complement-mediated reaction, a property associated with protection. However, in contrast to gp90, previously shown to induce protective immunity against acute T. cruzi infection, gp82 was not immunoprotective. Lymph node (LN) cells of mice primed with gp82 or gp90, which display 40% amino acid sequence identity at the carboxy terminal domain, were strongly stimulated in vitro by either one of these antigens. Proliferation, inhibitable by anti-CD4 but not by anti-CD8 antibodies, was T. cruzi-specific, no activation being observed with irrelevant antigens. LN cells of mice immunized with unrelated proteins did not proliferate in vitro in the presence of gp82 or gp90. The 35/50-kDa glycoconjugate, which was phenol-extracted, did not elicit any detectable antibody or T cell response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253154     DOI: 10.1006/expr.1993.1100

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  6 in total

1.  Infectivity of Trypanosoma cruzi strains is associated with differential expression of surface glycoproteins with differential Ca2+ signalling activity.

Authors:  R C Ruiz; S Favoreto; M L Dorta; M E Oshiro; A T Ferreira; P M Manque; N Yoshida
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Involvement of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 in adhesion to gastric mucin and invasion of epithelial cells.

Authors:  Ivan Neira; Fernando A Silva; Mauro Cortez; Nobuko Yoshida
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection.

Authors:  R Santori F; G S Paranhos-Bacalla; J Franco DA Silveira; L M Yamauchi; J E Araya; N Yoshida
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

4.  Dynamics of Lymphocyte Populations during Trypanosoma cruzi Infection: From Thymocyte Depletion to Differential Cell Expansion/Contraction in Peripheral Lymphoid Organs.

Authors:  Alexandre Morrot; Juliana Barreto de Albuquerque; Luiz Ricardo Berbert; Carla Eponina de Carvalho Pinto; Juliana de Meis; Wilson Savino
Journal:  J Trop Med       Date:  2012-02-12

5.  Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.

Authors:  Christopher S Eickhoff; Jose R Vasconcelos; Nicole L Sullivan; Azra Blazevic; Oscar Bruna-Romero; Mauricio M Rodrigues; Daniel F Hoft
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

6.  Trypanosoma cruzi Entrance through Systemic or Mucosal Infection Sites Differentially Modulates Regional Immune Response Following Acute Infection in Mice.

Authors:  Juliana de Meis; Juliana Barreto de Albuquerque; Danielle Silva Dos Santos; Désio Aurélio Farias-de-Oliveira; Luiz Ricardo Berbert; Vinícius Cotta-de-Almeida; Wilson Savino
Journal:  Front Immunol       Date:  2013-07-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.